David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$757M |
| 2 |
Alibaba
BABA
|
+$544M |
| 3 |
Booking.com
BKNG
|
+$475M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$377M |
| 5 |
Caterpillar
CAT
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.07B |
| 2 |
Amazon
AMZN
|
+$486M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$443M |
| 4 |
Salesforce
CRM
|
+$363M |
| 5 |
Qualcomm
QCOM
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Consumer Discretionary | 9.92% |
| 3 | Healthcare | 7.34% |
| 4 | Financials | 7.06% |
| 5 | Communication Services | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
John B. Sanfilippo & Son
JBSS
$877M
| $266K | ﹤0.01% |
3,253
| – | – |
|
4277
Bassett Furniture
BSET
$163M
| $265K | ﹤0.01% |
+14,653
| New | +$321K |
|
|
CHCT
4278
Community Healthcare Trust
CHCT
$425M
| $265K | ﹤0.01% |
+5,874
| New | +$285K |
|
|
SNCY
4279
DELISTED
Sun Country Airlines
SNCY
| $265K | ﹤0.01% |
+7,894
| New | +$263K |
|
4280
CALL
Cal-Maine
CALM
$3.93B
| $264K | ﹤0.01% |
7,300
| – | – |
|
4281
Diodes
DIOD
$4.17B
| $264K | ﹤0.01% |
2,918
-1,083
| -27% | -$94.6K |
|
|
COOP
4282
DELISTED
Mr. Cooper
COOP
| $263K | ﹤0.01% |
6,389
-27,783
| -81% | -$1.05M |
|
4283
Federated Hermes
FHI
$4.85B
| $263K | ﹤0.01% |
8,105
-52,096
| -87% | -$1.7M |
|
4284
PUT
Zai Lab
ZLAB
$2.96B
| $263K | ﹤0.01% |
2,500
| – | – |
|
|
ABTC
4285
American Bitcoin Corp
ABTC
$663M
| $263K | ﹤0.01% |
+3
| New | +$306K |
|
4286
CALL
Capri Holdings
CPRI
$1.52B
| $261K | ﹤0.01% |
5,400
-101,100
| -95% | -$5.51M |
|
4287
CALL
Chubb
CB
$132B
| $260K | ﹤0.01% |
+1,500
| New | +$263K |
|
4288
Cadiz
CDZI
$351M
| $260K | ﹤0.01% |
36,925
-78,827
| -68% | -$969K |
|
|
NOAH
4289
CALL
Noah Holdings
NOAH
$603M
| $260K | ﹤0.01% |
7,000
-400
| -5% | -$15.8K |
|
4290
AXIS Capital
AXS
$7.22B
| $259K | ﹤0.01% |
5,626
-7,683
| -58% | -$381K |
|
|
SUM
4291
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $259K | ﹤0.01% |
8,247
+2,283
| +38% | +$74.5K |
|
|
DENN
4292
DELISTED
Denny's
DENN
| $258K | ﹤0.01% |
+15,781
| New | +$248K |
|
4293
Core Laboratories
CLB
$551M
| $257K | ﹤0.01% |
9,276
-6,941
| -43% | -$211K |
|
|
RVNC
4294
DELISTED
Revance Therapeutics, Inc.
RVNC
| $257K | ﹤0.01% |
9,240
-38,847
| -81% | -$1.11M |
|
4295
PetMed Express
PETS
$38.2M
| $256K | ﹤0.01% |
9,532
-45,443
| -83% | -$1.31M |
|
|
RPT
4296
Rithm Property Trust
RPT
$103M
| $256K | ﹤0.01% |
+3,166
| New | +$254K |
|
|
JNCE
4297
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $256K | ﹤0.01% |
34,388
-44,535
| -56% | -$276K |
|
4298
Terreno Realty
TRNO
$7.43B
| $255K | ﹤0.01% |
4,036
-31,262
| -89% | -$2.08M |
|
4299
MSCI
MSCI
$41.2B
| $254K | ﹤0.01% |
418
-156
| -27% | -$95.3K |
|
4300
Enliven Therapeutics
ELVN
$4.47B
| $253K | ﹤0.01% |
+15,498
| New | +$322K |
|
Similar funds
David Shaw's Q3 2021 Portfolio in Review
As of Q3 2021, David Shaw held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
David Shaw withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Sea Limited worth $206M.
- David Shaw's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
- David Shaw added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
- David Shaw's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
- David Shaw fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
- David Shaw's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
- David Shaw opened 915 new positions and closed 695 in Q3 2021.
- David Shaw's portfolio value fell 4.4% quarter-over-quarter to $111B.
Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.